Affiliation:
1. From the Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA.
Abstract
Infection with the severe acute respiratory syndrome novel coronavirus produces a clinical syndrome known as 2019 novel coronavirus disease (COVID-19). When severe, COVID-19 is a systemic illness characterized by hyperinflammation, cytokine storm, and elevations of cardiac injury biomarkers. Here, we review what is known about the pathophysiology of COVID-19, its cardiovascular manifestations, and emerging therapeutic prospects. In this rapidly moving field, this review was comprehensive as of April 3, 2020.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine,Physiology
Reference98 articles.
1. World Health Organization. Coronavirus disease 2019 (COVID-19): situation reports. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/. Accessed April 3 2020.
2. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
3. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China [published online March 3, 2020].;Ruan Q;Intensive Care Med,2020
4. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
5. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China
Cited by
569 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献